Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 20, 2026 04:00 ET | Source: AKAMPION

Atopia Therapeutics Reports Preclinical Proof-of-Concept of Lead Compound ATP-R13 in Atopic Dermatitis and Strengthens Patent Protection

Preclinical in vivo efficacy data (PoC) in atopic dermatitis of disease-modifying therapy; positive patent opinion from the EU Patent Office